We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.31%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
ING
ING
$101B
| $34M | 0.17% |
2,421,988
+919,515
| +61% | +$12.9M |
|
|
CERN
127
DELISTED
Cerner Corp
CERN
| $33.5M | 0.17% |
649,927
-1,168,756
| -64% | -$61.5M |
|
128
FirstEnergy
FE
$28B
| $33.5M | 0.17% |
963,689
-84,899
| -8% | -$2.86M |
|
129
Constellation Brands
STZ
$22.4B
| $33.4M | 0.17% |
378,736
+279,591
| +282% | +$23.1M |
|
|
WPX
130
DELISTED
WPX Energy, Inc.
WPX
| $33.1M | 0.17% |
1,382,740
+1,237,252
| +850% | +$26.3M |
|
|
AZPN
131
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $33M | 0.17% |
711,616
+203,691
| +40% | +$9.45M |
|
|
TLM
132
DELISTED
TALISMAN ENERGY INC
TLM
| $32.5M | 0.17% |
+3,072,728
| New | +$32.1M |
|
|
EGN
133
DELISTED
Energen
EGN
| $32.5M | 0.17% |
365,831
+313,590
| +600% | +$26.4M |
|
134
Synaptics
SYNA
$4.13B
| $32.3M | 0.17% |
356,014
+58,860
| +20% | +$3.99M |
|
|
BT
135
DELISTED
BT Group plc (ADR)
BT
| $32.2M | 0.17% |
981,310
-41,174
| -4% | -$1.32M |
|
136
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $32.1M | 0.16% |
163,816
+26,700
| +19% | +$5.08M |
|
137
Moody's
MCO
$83.7B
| $30.8M | 0.16% |
351,132
-20,724
| -6% | -$1.71M |
|
|
HAR
138
DELISTED
Harman International Industries
HAR
| $30.4M | 0.16% |
+283,032
| New | +$30.1M |
|
|
NFX
139
DELISTED
Newfield Exploration
NFX
| $30.2M | 0.16% |
683,875
+480,677
| +237% | +$17.2M |
|
140
Electronic Arts
EA
$53B
| $30.2M | 0.16% |
842,117
+741,151
| +734% | +$24.1M |
|
|
LFC
141
DELISTED
China Life Insurance Company Ltd.
LFC
| $30.1M | 0.16% |
2,306,346
-10,269
| -0.4% | -$139K |
|
142
Comstock Resources
CRK
$3.94B
| $30.1M | 0.15% |
208,494
+173,821
| +501% | +$22.9M |
|
143
Wynn Resorts
WYNN
$10.2B
| $30M | 0.15% |
+144,722
| New | +$30M |
|
144
Oracle
ORCL
$409B
| $29.8M | 0.15% |
+735,435
| New | +$30.3M |
|
|
UPL
145
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $29.6M | 0.15% |
998,302
+767,854
| +333% | +$21.8M |
|
|
CFN
146
DELISTED
CAREFUSION CORPORATION
CFN
| $29.6M | 0.15% |
667,159
-738,834
| -53% | -$30.6M |
|
|
SJR
147
DELISTED
Shaw Communications Inc.
SJR
| $29.5M | 0.15% |
1,147,893
+81,560
| +8% | +$2M |
|
|
ARRS
148
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $29.1M | 0.15% |
893,038
+416,775
| +88% | +$12.3M |
|
|
PVA
149
DELISTED
PENN VIRGINIA CORP
PVA
| $29M | 0.15% |
1,708,258
+1,411,768
| +476% | +$22.4M |
|
150
APA Corp
APA
$13B
| $28.8M | 0.15% |
285,737
+207,921
| +267% | +$18.8M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.